Lendvai, N., Hilden, P., Devlin, S., Landau, H., Hassoun, H., Lesokhin, A. M., . . . Giralt, S. A. (2014). A phase 2 single-center study of carfilzomib 56 mg/m(2) with or without low-dose dexamethasone in relapsed multiple myeloma. Blood.
Stile di citazione ChicagoLendvai, Nikoletta, et al. "A Phase 2 Single-center Study of Carfilzomib 56 Mg/m(2) With or Without Low-dose Dexamethasone in Relapsed Multiple Myeloma." Blood 2014.
Citazione MLALendvai, Nikoletta, et al. "A Phase 2 Single-center Study of Carfilzomib 56 Mg/m(2) With or Without Low-dose Dexamethasone in Relapsed Multiple Myeloma." Blood 2014.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.